Korro Bio (KRRO) Selling, General & Administrative (2018 - 2026)
Korro Bio's Selling, General & Administrative came in at $6.52 million for Q2 2026, down 10.6% from $7.29 million a year earlier and down 12.9% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Korro Bio reported Selling, General & Administrative of $26.7 million, down 13.3% year-over-year; for FY2025, it was $28.16 million, down 7.8% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $30.55 million in FY2024 (+12.0%), $27.28 million in FY2023 (+62.4%), $16.8 million in FY2022 (-54.8%) and $37.18 million in FY2021 (+37.1%).
- The five-year range for quarterly Selling, General & Administrative is -$9.24 million (Q4 2022) to $11.47 million (Q4 2023).
- Year-over-year, Selling, General & Administrative has declined for four consecutive quarters, with an average decline of 4.1% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2024 (growth of 46.2%), and the weakest in Q1 2023 (a decline of 43.1%).
- Business Quant data shows KRRO's Selling, General & Administrative at $7.49 million (Q1 2026), $6.19 million (Q4 2025) and $6.51 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Korro Bio | 142.79 Mn | -253.85 Mn | - | 6.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.52 Mn |
| Mar 31, 2026 | 7.49 Mn |
| Dec 31, 2025 | 6.19 Mn |
| Sep 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | 7.83 Mn |
| Dec 31, 2024 | 8.35 Mn |
| Sep 30, 2024 | 7.33 Mn |
| Jun 30, 2024 | 6.99 Mn |
| Mar 31, 2024 | 7.88 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 5.28 Mn |
| Mar 31, 2023 | 5.39 Mn |
| Dec 31, 2022 | -9.24 Mn |
| Sep 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 9.48 Mn |
| Dec 31, 2021 | 8.61 Mn |
| Sep 30, 2021 | 9.33 Mn |
API Access
Korro Bio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();